sur Schutzgemeinschaft Der Kapitalanleger E.V.
SdK Offers Litigation Finance to Former STADA Shareholders
SdK Schutzgemeinschaft der Kapitalanleger e.V. is offering litigation finance to former shareholders of STADA Arzneimittel AG. These shareholders, who tendered their shares during the takeover by Nidda Healthcare Holding AG in August or September 2017, are entitled to an additional payment of €8.15 per share. This follows a May 2023 decision by the Federal Court of Justice.
Despite the ruling, Nidda Healthcare has refused voluntary payment. Therefore, SdK provides litigation financing with no cost risk to affected former shareholders. This funding will cover all legal costs in exchange for a 30% profit participation from the proceeds in case of a successful claim.
Information on how to proceed and contact details are available for the former shareholders wishing to enforce their claims. SdK is committed to assisting them throughout the process.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Schutzgemeinschaft Der Kapitalanleger E.V.